R. Geoffrey Sargent
Founder at GENETETHER THERAPEUTICS INC.
Net worth: 34 875 $ as of 29/04/2024
Profile
Dr. R.
G.
Sargent is a Chief Scientific Officer at GeneTether Therapeutics, Inc. and a Director & Chief Scientific Officer at GeneTether, Inc. He is on the Board of Directors at GeneTether, Inc. Dr. Sargent was previously employed as a Chief Scientific Officer by Onconetics Pharmaceuticals, Inc. He received his undergraduate degree from Georgia Institute of Technology and a doctorate degree from Oregon State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 17/10/2023 | 775,000 ( 2.00% ) | 34 875 $ | 29/04/2024 |
R. Geoffrey Sargent active positions
| Companies | Position | Start |
|---|---|---|
| GENETETHER THERAPEUTICS INC. | Founder | 11/02/2018 |
GeneTether, Inc.
 GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Founder | 11/02/2018 |
Former positions of R. Geoffrey Sargent
| Companies | Position | End |
|---|---|---|
Onconetics Pharmaceuticals, Inc.
 Onconetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onconetics Pharmaceuticals, Inc. develops personalized gene therapies for cancers and other genetic disorders. The company was founded by Luke Gruenert and Gabriel Hitchcock and is headquartered in mill valley, CA. | Chief Tech/Sci/R&D Officer | 28/02/2018 |
Training of R. Geoffrey Sargent
| Georgia Institute of Technology | Undergraduate Degree |
| Oregon State University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| GENETETHER THERAPEUTICS INC. | Health Technology |
| Private companies | 2 |
|---|---|
Onconetics Pharmaceuticals, Inc.
Onconetics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onconetics Pharmaceuticals, Inc. develops personalized gene therapies for cancers and other genetic disorders. The company was founded by Luke Gruenert and Gabriel Hitchcock and is headquartered in mill valley, CA. | Health Technology |
GeneTether, Inc.
GeneTether, Inc. Miscellaneous Commercial ServicesCommercial Services GeneTether, Inc. develops gene editing technologies intended for human therapeutic applications. Its platform is focused on the treatment of rare, monogenic diseases of the kidney and the skin. The company was founded by William James Garner, R. Geoffrey Sargent, and Daren N. Graham on February 12, 2018 and is headquartered on California. | Commercial Services |
- Stock Market
- Insiders
- R. Geoffrey Sargent
